| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-12 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-10 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-10 |
| mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |